睡眠補助薬市場規模、シェア、成長分析、製品タイプ別、睡眠障害別、流通チャネル別、エンドユーザー別、地域別 - 産業別予測、2024～2031年

睡眠補助薬の世界市場規模は2022年に780億米ドルと評価され、予測期間（2024-2031年）のCAGRは5.4%で、2023年の822億1,000万米ドルから2031年には1,252億2,000万米ドルに成長する見通しです。

睡眠障害は日常機能に大きな影響を及ぼし、日中の過度の眠気を助長し、学業や職業環境、精神的幸福、対人関係、心臓病や糖尿病などの慢性疾患のリスクなどの課題を悪化させる。一般的な疾患には、不眠症、睡眠時無呼吸症候群、レストレスレッグス症候群、ナルコレプシーなどがあります。治療の選択肢は、ピトリサント、モダフィニル、アルモダフィニルなどの医薬品から、メラトニンやザレプロンなどの治療薬や市販のサプリメントまで多岐にわたる。運動や環境制御などの生活習慣の調整は睡眠の質を高めることができるが、薬の潜在的な副作用や患者の非服従率の高さが睡眠補助薬市場の成長を妨げる可能性があります。2024年に向けて、これらの課題に対処することは、睡眠の健康増進を目指す市場利害関係者やヘルスケアプロバイダーにとって極めて重要です。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2023年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• 特許分析
• ケーススタディ
• 顧客と購買基準の分析

睡眠補助薬市場規模：製品タイプ別

• 市場概要
• マットレスと枕
• 医薬品
  • 処方箋に基づく
  • 店頭販売（OTC）
• 睡眠時無呼吸症候群用装置
  • 気道陽圧（PAP）装置
  • 適応サーボ換気（ASV）装置
  • 口腔装置
  • マスクとアクセサリー
• 睡眠研究所
• その他の製品
  • 睡眠追跡デバイス
  • ホワイトノイズマシン

睡眠補助薬市場規模：睡眠障害別

• 市場概要
• 不眠症
• 睡眠時無呼吸症候群
• むずむず脚症候群
• ナルコレプシー
• 夢遊病
• その他の睡眠障害

睡眠補助薬市場規模：流通チャネル別

• 市場概要
• 小売薬局
• 病院薬局
• オンライン薬局
• 睡眠クリニック
• その他

睡眠補助薬市場規模：エンドユーザー別

• 市場概要
• 大人
• 子供
• 高齢者

睡眠補助薬市場規模：地域別

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2021-2023）

主要企業プロファイル

• Merck & Co., Inc.（USA）
• Sanofi（France）
• Koninklijke Philips N.V.（Netherlands）
• Pfizer Inc.（USA）
• GlaxoSmithKline PLC（UK）
• SleepMed Inc.（USA）
• Cadwell Laboratories Inc.（USA）
• Natus Medical Incorporated（USA）
• Fisher & Paykel Healthcare（New Zealand）
• ResMed Inc.（USA）
• Teva Pharmaceutical Industries Ltd.（Israel）
• AstraZeneca（UK）
• Takeda Pharmaceutical Company Limited（Japan）
• Vanda Pharmaceuticals Inc.（USA）
• Mylan N.V.（USA）
• Koninklijke Philips N.V.（Netherlands）

結論と推奨事項

Global Sleep Aids Market size was valued at USD 78.0 billion in 2022 and is poised to grow from USD 82.21 billion in 2023 to USD 125.22 billion by 2031, growing at a CAGR of 5.4% during the forecast period (2024-2031).

Sleep disorders significantly affect daily functioning, contributing to excessive daytime sleepiness and exacerbating challenges in academic and professional settings, mental well-being, interpersonal relationships, and the risk of chronic conditions like heart disease and diabetes. Common disorders include insomnia, sleep apnea, restless legs syndrome, and narcolepsy. Treatment options range from pharmaceutical solutions such as pitolisant, modafinil, and armodafinil to therapies and over-the-counter supplements like melatonin and zaleplon. While lifestyle adjustments like exercise and environmental control can enhance sleep quality, potential side effects of medications and high rates of patient non-adherence may hinder growth in the sleep aids market. As we approach 2024, addressing these challenges will be crucial for market stakeholders and healthcare providers aiming to improve sleep health.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Sleep Aids market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Sleep Aids Market Segmental Analysis

Global Sleep Aids Market is segmented by product type, sleep disorder, distribution channel, end-user and region. Based on product type, the market is segmented into mattresses & pillows, medications, sleep apnea devices, sleep laboratories and other products. Based on sleep disorder, the market is segmented into insomnia, sleep apnea, restless legs syndrome, narcolepsy, sleepwalking and other sleep disorders. Based on distribution channel, the market is segmented into retail pharmacies, hospital pharmacies, online pharmacies, sleep clinics and others. Based on end-user, the market is segmented into adults, children and elderly. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Sleep Aids Market

The primary impetus behind the expansion of the global sleep aids market is the evolving sleep patterns among people, driven by contemporary lifestyles. As individuals grapple with increased stress, demanding work schedules, and technology-induced sleep disruption, the need for effective sleep solutions has surged. Additionally, rising disposable incomes and enhanced healthcare access are likely to further fuel the demand for sleep aids over the coming years. This convergence of factors-modern living challenges and heightened health consciousness-positions the sleep aids market for robust growth in the foreseeable future, as consumers seek out products that promote better sleep quality and overall well-being.

Restraints in the Global Sleep Aids Market

The Global Sleep Aids market faces significant challenges due to the rising complexity of treating sleep disorders driven by advanced technological innovations. Moreover, the absence of adequate regulatory documentation for the prescription and utilization of sleep medications, coupled with improper settings on sleep devices, hampers effective treatment options. These issues contribute to a stagnation in market growth, as consumers and healthcare providers grapple with the limitations of current solutions. As a result, the potential for expansion in the sleep aids market is stifled, hindering advancements in product development and overall accessibility to effective treatment alternatives for individuals experiencing sleep disturbances.

Market Trends of the Global Sleep Aids Market

The Global Sleep Aids market is experiencing significant growth, driven by rising consumer awareness of sleep-related disorders and the increasing prevalence of issues such as restless leg syndrome and narcolepsy. Innovative products like sleep-inducing pillows and mattresses are gaining traction among health-conscious consumers seeking better sleep quality. The burgeoning demand for both pharmaceutical and non-pharmaceutical sleep solutions reflects a broader trend towards holistic wellness. As people continue to prioritize sleep as a critical factor in overall health, the market is poised for further expansion, generating substantial revenue opportunities for manufacturers and suppliers within the sleep aids sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Patent Analysis
• Case Studies
• Customer & Buying Criteria Analysis

Global Sleep Aids Market Size by Product Type & CAGR (2024-2031)

• Market Overview
• Mattresses & Pillows
• Medications
  • Prescription-Based
  • Over-The-Counter (OTC)
• Sleep Apnea Devices
  • Positive Airway Pressure (PAP) Devices
  • Adaptive Servo-Ventilation (ASV) Devices
  • Oral Appliances
  • Masks & Accessories
• Sleep Laboratories
• Other Products
  • Sleep Tracking Devices
  • White Noise Machines

Global Sleep Aids Market Size by Sleep Disorder & CAGR (2024-2031)

• Market Overview
• Insomnia
• Sleep Apnea
• Restless Legs Syndrome
• Narcolepsy
• Sleep Walking
• Other Sleep Disorders

Global Sleep Aids Market Size by Distribution Channel & CAGR (2024-2031)

• Market Overview
• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies
• Sleep Clinics
• Others

Global Sleep Aids Market Size by End-User & CAGR (2024-2031)

• Market Overview
• Adults
• Children
• Elderly

Global Sleep Aids Market Size & CAGR (2024-2031)

• North America (Product Type, Sleep Disorder, Distribution Channel, End-User)
  • USA
  • Canada
• Europe (Product Type, Sleep Disorder, Distribution Channel, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Sleep Disorder, Distribution Channel, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Sleep Disorder, Distribution Channel, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Sleep Disorder, Distribution Channel, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SleepMed Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cadwell Laboratories Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Natus Medical Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fisher & Paykel Healthcare (New Zealand)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ResMed Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vanda Pharmaceuticals Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations